ESCMID Celebrates the 10th edition of the International Day of Women and Girls in Science by sitting down with two important leaders within ESCMID. Giulia De Angelis is the Associate Programme Director for ESCMID Global and Angela Huttner is the Editor-in-Chief of the new ESCMID journal, CMI Communications. They give their personal views on the importance of equality in scientific publishing and how it enriches our congress.

Congress & Events

The submission period for late-breaking abstracts for ESCMID Global 2025 is closing soon on 14 February 2025. Late-breaking Abstracts must pertain to new data that has not been published and was generated after regular abstracts submission was closed. For this year, we will exclusively consider abstracts falling within the following categories: New drugs and vaccines, Clinical trials, New and emerging pathogens, or Outbreaks and public health emergencies.

Join us at ESCMID Global 2025 for the AMR Science-Policy forum where scientists and policy makers meet to bridge the gap between science and policy on AMR. Two main sessions will take place:

• Science to inform policy: Implementing UNGA targets on AMR
• Policy to drive action: Establishing the Independent Panel on Evidence for Action on AMR and updating the Global Action Plan
  
  

Stay tuned on our website for future updates.

Education

This course, organised by the ESCMID Study Group for Infections of the Brain (ESGIB) together with the Société de Pathologie Infectieuse de Langue Française (SPILF), has the objective to provide knowledge on model systems of brain infections to both young and established researchers with interactive sessions, methodological based workshops and structured discussions among the participants.

Explore how the microbiome shapes health, disease susceptibility, and therapeutic innovation. From immune modulation to resistance against pathogens, delve into groundbreaking research and learn to interpret complex bioinformatics, metagenomics, and metabolomics data. Don’t miss this opportunity to stay at the forefront of medical science – register now.

Science & Research

Join the new ESCMID Study Group, ESGUTI, which aims to bring together international experts on the diagnosis, pathophysiology, treatment, and prevention of urinary tract infections in order to improve understanding, management and prevention of these infections and to reduce the emergence of antimicrobial resistance in this population. Visit their website to learn more.

ESCMID is currently looking for two new members of the ESCMID Ethics Advisory Committee. Have a role in counselling on specific ethical, regulatory, social and philosophical issues related to ESCMID funded-research projects, as well as scientific behaviour of members or appointed persons in matters related to ESCMID activities.

The application deadline is 28 February 2025 so apply today!

Guidelines & Journals

Despite being preventable and curable, tuberculosis remains a major global health threat, infecting over 10 million people and claiming more than 1 million lives every year. Hosts Angela Huttner and Navaneeth Narayanan discuss the latest on tuberculosis with experts Lorenzo Guglielmetti of Doctors without Borders and Olha Konstantynovska of Kharkiv National University, Ukraine.

The yearly ESCMID course on systematic reviews, meta-analyses and the GRADE approach for guidelines development will be held in Rome, Italy, 19-22 May 2025. The course is a mix of interactive lectures and practical exercises and is intended for junior clinicians and researchers. The course is free of charge, but attendance requires submitting an application for review before the deadline of 26 February 2025.

Long-term outcomes of passive immunotherapy for COVID-19: A pooled analysis of a large multinational platform randomized clinical trial

Optimizing use of the (1-3)-β-D-Glucan Assay for the Diagnosis of Pneumocystis jirovecii Pneumonia